Press Release - December 2005, January 2006, March 2006

Posted in: News & Events
By Press Release
Mar 24, 2006 - 12:44:30 PM

December, 2005:

AndroScience Corporation and its CEO, Dr. Charles Shih, were referred to and discussed as one of the Biotech Companies with a Taiwan connection in an article regarding Taiwan’s strong Biotech industry. The article, titled “Taiwan Industry Puts Strong Focus on Biotech”, appeared in Genetic Engineering News, Volume 25, Number 21, December 2005, p.56.



December 22, 2005:

AndroScience announces it had a successful pre-IND Meeting with the FDA for its lead drug candidate ASC-J9 for topical application of acne vulgaris. An IND and Clinical Trials are planned for 2006.


January, 2006:

Dr. Charles Shih, CEO of AndroScience Corporation, was pictured and mentioned in an article by Katie Weeks, titled “Biotech Scene Has Taiwanese Accent”, in the San Diego Business Journal, Volume 27, Number 2, January 9-15, 2006.



March, 2006:

American Academy of Dermatology (AAD) Poster Award: Dr. Charles Shih, CEO of AndroScience Corp. presented a poster titled “Androgen receptor degradation enhancer: A potential application for topical treatment of acne vulgaris" on March 4, 2006 at the 64th Annual AAD Meeting in San Francisco. The poster from AndroScience won the third place award out of 1000 posters displayed at the AAD Meeting. The announcement is on page 4 of the AAD Annual Meeting News.


 
Home | Corporate Overview | Product Pipeline | Science & Technology | News & Events | Contact Us | Privacy Policy